Loading...

Cross Country Healthcare

Nasdaq:CCRN
Snowflake Description

Excellent balance sheet and fair value.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
CCRN
Nasdaq
$254M
Market Cap
  1. Home
  2. US
  3. Healthcare
Company description

Cross Country Healthcare, Inc. provides healthcare staffing, recruiting, and workforce solutions in the United States. The last earnings update was 49 days ago. More info.


Add to Portfolio Compare Print
  • Cross Country Healthcare has significant price volatility in the past 3 months.
CCRN Share Price and Events
7 Day Returns
-6%
NasdaqGS:CCRN
-5.3%
US Healthcare
0.2%
US Market
1 Year Returns
-42.5%
NasdaqGS:CCRN
-5.5%
US Healthcare
6.3%
US Market
CCRN Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Cross Country Healthcare (CCRN) -6% -3.6% -24.2% -42.5% -45.8% -0.3%
US Healthcare -5.3% -10% -11.9% -5.5% 11.3% 59.5%
US Market 0.2% 2.1% 8.5% 6.3% 37.9% 45.7%
1 Year Return vs Industry and Market
  • CCRN underperformed the Healthcare industry which returned -5.5% over the past year.
  • CCRN underperformed the Market in United States of America which returned 6.3% over the past year.
Price Volatility
CCRN
Industry
5yr Volatility vs Market

Value

 Is Cross Country Healthcare undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Cross Country Healthcare to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Cross Country Healthcare.

NasdaqGS:CCRN Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 8 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 8.3%
Perpetual Growth Rate 10-Year US Government Bond Rate 2.7%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for NasdaqGS:CCRN
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year US Govt Bond Rate 2.7%
Equity Risk Premium S&P Global 6%
Healthcare Unlevered Beta Simply Wall St/ S&P Global 0.71
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.712 (1 + (1- 21%) (32.78%))
0.93
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.93
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.73% + (0.93 * 5.96%)
8.28%

Discounted Cash Flow Calculation for NasdaqGS:CCRN using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Cross Country Healthcare is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

NasdaqGS:CCRN DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 8.28%)
2019 14.44 Analyst x4 13.33
2020 25.39 Analyst x4 21.66
2021 32.00 Analyst x1 25.21
2022 37.42 Est @ 16.95% 27.23
2023 42.17 Est @ 12.68% 28.34
2024 46.26 Est @ 9.7% 28.71
2025 49.77 Est @ 7.61% 28.53
2026 52.83 Est @ 6.14% 27.97
2027 55.54 Est @ 5.12% 27.15
2028 57.98 Est @ 4.4% 26.18
Present value of next 10 years cash flows $254.30
NasdaqGS:CCRN DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= $57.98 × (1 + 2.73%) ÷ (8.28% – 2.73%)
$1,074.08
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $1,074.08 ÷ (1 + 8.28%)10
$484.99
NasdaqGS:CCRN Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $254.30 + $484.99
$739.29
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $739.29 / 36.14
$20.45
NasdaqGS:CCRN Discount to Share Price
Calculation Result
Value per share (USD) From above. $20.45
Current discount Discount to share price of $7.02
= -1 x ($7.02 - $20.45) / $20.45
65.7%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Cross Country Healthcare is available for.
Intrinsic value
>50%
Share price is $7.02 vs Future cash flow value of $20.45
Current Discount Checks
For Cross Country Healthcare to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Cross Country Healthcare's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Cross Country Healthcare's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Cross Country Healthcare's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Cross Country Healthcare's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NasdaqGS:CCRN PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in USD $-0.48
NasdaqGS:CCRN Share Price ** NasdaqGS (2019-04-18) in USD $7.02
United States of America Healthcare Industry PE Ratio Median Figure of 53 Publicly-Listed Healthcare Companies 20.9x
United States of America Market PE Ratio Median Figure of 3,081 Publicly-Listed Companies 18.15x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Cross Country Healthcare.

NasdaqGS:CCRN PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NasdaqGS:CCRN Share Price ÷ EPS (both in USD)

= 7.02 ÷ -0.48

-14.77x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Cross Country Healthcare is loss making, we can't compare its value to the US Healthcare industry average.
  • Cross Country Healthcare is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does Cross Country Healthcare's expected growth come at a high price?
Raw Data
NasdaqGS:CCRN PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -14.77x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 8 Analysts
97.3%per year
United States of America Healthcare Industry PEG Ratio Median Figure of 40 Publicly-Listed Healthcare Companies 1.48x
United States of America Market PEG Ratio Median Figure of 2,109 Publicly-Listed Companies 1.57x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Cross Country Healthcare, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Cross Country Healthcare's assets?
Raw Data
NasdaqGS:CCRN PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in USD $6.11
NasdaqGS:CCRN Share Price * NasdaqGS (2019-04-18) in USD $7.02
United States of America Healthcare Industry PB Ratio Median Figure of 92 Publicly-Listed Healthcare Companies 2.33x
United States of America Market PB Ratio Median Figure of 5,178 Publicly-Listed Companies 1.91x
NasdaqGS:CCRN PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NasdaqGS:CCRN Share Price ÷ Book Value per Share (both in USD)

= 7.02 ÷ 6.11

1.15x

* Primary Listing of Cross Country Healthcare.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Cross Country Healthcare is good value based on assets compared to the US Healthcare industry average.
X
Value checks
We assess Cross Country Healthcare's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. Cross Country Healthcare has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Cross Country Healthcare expected to perform in the next 1 to 3 years based on estimates from 8 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
97.3%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Cross Country Healthcare expected to grow at an attractive rate?
  • Cross Country Healthcare's earnings growth is expected to exceed the low risk savings rate of 2.7%.
Growth vs Market Checks
  • Cross Country Healthcare's earnings growth is expected to exceed the United States of America market average.
  • Cross Country Healthcare's revenue growth is positive but not above the United States of America market average.
Annual Growth Rates Comparison
Raw Data
NasdaqGS:CCRN Future Growth Rates Data Sources
Data Point Source Value (per year)
NasdaqGS:CCRN Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 8 Analysts 97.3%
NasdaqGS:CCRN Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 8 Analysts 1.9%
United States of America Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 13.2%
United States of America Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 7.1%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 13.3%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NasdaqGS:CCRN Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 8 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NasdaqGS:CCRN Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2021-12-31 886 38 27 1
2020-12-31 841 31 12 8
2019-12-31 807 22 2 8
NasdaqGS:CCRN Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2018-12-31 816 21 -17
2018-09-30 835 39 31
2018-06-30 863 38 38
2018-03-31 868 57 41
2017-12-31 865 46 38
2017-09-30 868 27 2
2017-06-30 854 43 9
2017-03-31 845 29 -13
2016-12-31 834 30 8
2016-09-30 804 32 10
2016-06-30 785 25 1
2016-03-31 778 21 21

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Cross Country Healthcare's earnings are expected to grow significantly at over 20% yearly.
  • Cross Country Healthcare's revenue is expected to grow by 1.9% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NasdaqGS:CCRN Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 8 Analyst Estimates (S&P Global) See Below

All data from Cross Country Healthcare Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqGS:CCRN Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2021-12-31 0.56 0.56 0.56 1.00
2020-12-31 0.30 0.58 0.12 6.00
2019-12-31 0.04 0.16 -0.08 6.00
NasdaqGS:CCRN Past Financials Data
Date (Data in USD Millions) EPS *
2018-12-31 -0.48
2018-09-30 0.86
2018-06-30 1.06
2018-03-31 1.15
2017-12-31 1.07
2017-09-30 0.05
2017-06-30 0.27
2017-03-31 -0.40
2016-12-31 0.25
2016-09-30 0.30
2016-06-30 0.02
2016-03-31 0.65

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Cross Country Healthcare is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Cross Country Healthcare's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Cross Country Healthcare has a total score of 3/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Cross Country Healthcare performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Cross Country Healthcare's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Cross Country Healthcare does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.
  • Unable to compare Cross Country Healthcare's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Cross Country Healthcare's 1-year growth to the US Healthcare industry average as it is not currently profitable.
Earnings and Revenue History
Cross Country Healthcare's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Cross Country Healthcare Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqGS:CCRN Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 816.48 -16.95 182.43
2018-09-30 835.25 30.69 183.32
2018-06-30 863.02 37.85 186.51
2018-03-31 867.76 41.17 187.54
2017-12-31 865.05 37.51 189.26
2017-09-30 867.90 1.68 188.65
2017-06-30 854.40 9.02 186.81
2017-03-31 844.53 -13.07 184.79
2016-12-31 833.54 7.97 180.41
2016-09-30 804.16 9.75 174.25
2016-06-30 784.87 0.70 168.08
2016-03-31 778.04 20.51 164.20
2015-12-31 767.42 4.42 162.27
2015-09-30 762.41 -9.70 163.89
2015-06-30 755.66 -22.31 165.23
2015-03-31 685.70 -28.07 153.40
2014-12-31 617.83 -31.78 142.03
2014-09-30 538.87 -64.49 127.46
2014-06-30 457.97 -55.43 112.06
2014-03-31 446.09 -53.69 109.60
2013-12-31 438.31 -54.25 107.20
2013-09-30 440.86 -4.31 107.19
2013-06-30 445.07 -5.05 108.57
2013-03-31 443.15 -22.45 109.69
2012-12-31 442.64 -20.75 110.20
2012-09-30 391.03 -19.78 100.43
2012-06-30 409.94 -18.71 102.54

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Cross Country Healthcare has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Cross Country Healthcare has efficiently used its assets last year compared to the US Healthcare industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Cross Country Healthcare improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Cross Country Healthcare's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Cross Country Healthcare has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Cross Country Healthcare's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Cross Country Healthcare's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Cross Country Healthcare is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Cross Country Healthcare's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Cross Country Healthcare's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 2.3x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Cross Country Healthcare Company Filings, last reported 3 months ago.

NasdaqGS:CCRN Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 218.20 83.18 16.02
2018-09-30 237.26 90.59 28.07
2018-06-30 236.87 96.74 32.56
2018-03-31 236.10 97.94 32.62
2017-12-31 237.72 99.13 25.54
2017-09-30 209.35 95.33 10.77
2017-06-30 201.65 35.34 33.94
2017-03-31 195.89 36.17 13.40
2016-12-31 151.80 87.00 20.63
2016-09-30 159.24 72.51 26.71
2016-06-30 144.28 79.77 10.23
2016-03-31 160.79 71.32 1.88
2015-12-31 141.34 89.37 2.45
2015-09-30 142.02 72.01 24.58
2015-06-30 136.55 71.76 8.68
2015-03-31 133.58 75.27 7.47
2014-12-31 130.33 74.07 5.00
2014-09-30 150.03 65.36 7.73
2014-06-30 157.24 64.80 9.29
2014-03-31 160.27 19.54 7.16
2013-12-31 160.67 8.58 8.06
2013-09-30 212.77 0.26 32.45
2013-06-30 211.55 0.36 25.92
2013-03-31 213.24 0.48 20.91
2012-12-31 209.12 33.86 10.46
2012-09-30 218.19 34.51 7.53
2012-06-30 234.48 36.23 7.87
  • Cross Country Healthcare's level of debt (38.1%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (5.4% vs 38.1% today).
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Whilst loss making Cross Country Healthcare has sufficient cash runway for more than 3 years if it maintains the current positive free cash flow level.
  • Whilst loss making Cross Country Healthcare has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by % per year.
X
Financial health checks
We assess Cross Country Healthcare's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Cross Country Healthcare has a total score of 5/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Cross Country Healthcare's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Cross Country Healthcare dividends. Estimated to be 0% next year.
If you bought $2,000 of Cross Country Healthcare shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Cross Country Healthcare's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Cross Country Healthcare's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NasdaqGS:CCRN Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 8 Analyst Estimates (S&P Global) See Below
United States of America Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 21 Stocks 1.6%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 2009 Stocks 2.4%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.4%
United States of America Top 25% Dividend Yield 75th Percentile 3.6%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

NasdaqGS:CCRN Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2021-12-31 0.00 1.00
2020-12-31 0.00 1.00
2019-12-31 0.00 1.00

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Cross Country Healthcare has not reported any payouts.
  • Unable to verify if Cross Country Healthcare's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Cross Country Healthcare's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Cross Country Healthcare has not reported any payouts.
Future Payout to shareholders
  • No need to calculate the sustainability of Cross Country Healthcare's dividends in 3 years as they are not expected to pay a notable one for United States of America.
X
Income/ dividend checks
We assess Cross Country Healthcare's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Cross Country Healthcare afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Cross Country Healthcare has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Cross Country Healthcare's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Kevin Clark
AGE 57
TENURE AS CEO 0.3 years
CEO Bio

Mr. Kevin C. Clark serves as the Chief Executive Officer of OGH, LLC. Mr. Clark serves as the Chairman and Chief Executive Officer of Onward Healthcare. He serves as a President, Chief Executive Officer & Director of Cross Country Healthcare since January 16, 2019. He also founded the Onward Healthcare in 2002. He served as the Chief Executive Officer at Pinnacor Inc., from November 1999 to January 2002. He has had a 25 year career as Chief Executive Officer of five rapidly growing healthcare companies and a founder of three. He served as the Chairman and Chief Executive Officer of KMC Holdings LLC from August 1998 to November 1999. He served as the Chairman and Chief Executive Officer of Poppe Tyson from May 1997 to May 1998. Previously he served as the Chief Executive Officer of Screaming Media and Onward Search. He Co-founded Cross Country Travcorps in 1986 and served as its Chief Executive Officer from 1986 to 1994. He served as the Chairman of Chief Executive Officer Advisory Board at Great Point Partners, LLC since 2003. He also served as the Chairman of Cross Country Travcorps from June 1994 to March 1996. He served as the Chairman of Pinnacor Inc., from May 2001 to November 2002. He served as Vice Chairman of Modem Media Poppe Tyson from May 1998 to August 1998. He serves on the Board of Healthmarket Inc., Pediatrix Inc., and Biotronic NeuroNetwork. He served as a Director of Pinnacor Inc. since November 1998. He served as a Director of HEI Exchange Inc., Icrossing, Inc., Interactive Video Technologies Inc. and Primary Knowledge, Inc. He served as a Director and Advisor to Poppe Tyson from March 1996 to May 1997.

CEO Compensation
  • Insufficient data for Kevin to compare compensation growth.
  • Insufficient data for Kevin to establish whether their remuneration is reasonable compared to companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the Cross Country Healthcare management team in years:

1.3
Average Tenure
51
Average Age
  • The average tenure for the Cross Country Healthcare management team is less than 2 years, this suggests a new team.
Management Team

Bill Burns

TITLE
Executive VP & CFO
COMPENSATION
$1M
AGE
48
TENURE
0.2 yrs

Susan Ball

TITLE
Executive VP
COMPENSATION
$831K
AGE
54
TENURE
14.9 yrs

Kevin Clark

TITLE
President
AGE
57
TENURE
0.3 yrs

Steve Saville

TITLE
Executive VP of Operations

Christopher Pizzi

TITLE
Chief Accounting Officer
COMPENSATION
$372K
AGE
47

Bill Halnon

TITLE
Chief Information Officer
AGE
59
TENURE
2.2 yrs

Kip Havel

TITLE
Senior VP & Chief Marketing Officer
AGE
41
TENURE
0.8 yrs

Daniele Addis

TITLE
Senior Vice President of Business Services
AGE
58
TENURE
5.3 yrs

John Gramer

TITLE
President of Cejka Search

Buffy White

TITLE
President of Travel Nurse & Allied and Workforce Solutions
AGE
44
TENURE
1.3 yrs
Board of Directors Tenure

Average tenure and age of the Cross Country Healthcare board of directors in years:

6.8
Average Tenure
64.5
Average Age
  • The tenure for the Cross Country Healthcare board of directors is about average.
Board of Directors

Tom Dircks

TITLE
Chairman of the Board
COMPENSATION
$265K
AGE
60
TENURE
5.7 yrs

Kevin Clark

TITLE
President
AGE
57
TENURE
0.3 yrs

W. Cash

TITLE
Director
COMPENSATION
$205K
AGE
69
TENURE
17.5 yrs

Joseph Trunfio

TITLE
Director
COMPENSATION
$195K
AGE
71
TENURE
17.5 yrs

Gale Fitzgerald

TITLE
Director
COMPENSATION
$190K
AGE
67
TENURE
11.9 yrs

Rich Mastaler

TITLE
Director
COMPENSATION
$180K
AGE
72
TENURE
7.8 yrs

Mark Perlberg

TITLE
Director
COMPENSATION
$180K
AGE
62
TENURE
3.9 yrs

Darrell Freeman

TITLE
Independent Director
AGE
53
TENURE
0.7 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
14. Nov 18 Buy Buffy White Individual 13. Nov 18 13. Nov 18 250 $8.25 $2,063
10. Sep 18 Buy Buffy White Individual 07. Sep 18 07. Sep 18 100 $9.50 $950
20. Aug 18 Buy Buffy White Individual 16. Aug 18 16. Aug 18 500 $9.25 $4,625
13. Aug 18 Buy Joseph Trunfio Individual 10. Aug 18 10. Aug 18 10,650 $9.43 $100,430
09. Aug 18 Buy Susan Ball Individual 09. Aug 18 09. Aug 18 5,091 $9.65 $49,128
09. Aug 18 Buy Thomas Dircks Individual 08. Aug 18 08. Aug 18 11,000 $9.07 $99,770
09. Aug 18 Buy William Grubbs Individual 08. Aug 18 08. Aug 18 10,000 $8.93 $89,300
11. May 18 Buy William Burns Individual 10. May 18 10. May 18 2,500 $11.92 $29,800
08. May 18 Buy W. Cash Individual 07. May 18 07. May 18 5,000 $11.14 $55,700
X
Management checks
We assess Cross Country Healthcare's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Cross Country Healthcare has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Is There An Opportunity With Cross Country Healthcare, Inc.'s (NASDAQ:CCRN) 35.75% Undervaluation?

I am going to run you through how I calculated the intrinsic value of Cross Country Healthcare, Inc. … by taking the foreast future cash flows of the company and discounting them back to today's value. … Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model.

Simply Wall St -

How Does Investing In Cross Country Healthcare, Inc. (NASDAQ:CCRN) Impact The Volatility Of Your Portfolio?

(NASDAQ:CCRN), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could impact your portfolio. … Some investors use beta as a measure of how much a certain stock is impacted by market risk (volatility). … A stock with a beta below one is either less volatile than the market, or more volatile but not corellated with the overall market.

Simply Wall St -

What does Cross Country Healthcare, Inc.'s (NASDAQ:CCRN) Balance Sheet Tell Us About Its Future?

While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, they end up ignoring a key aspect, which could be the biggest threat to its existence: its financial health. … Healthcare companies,. … So, understanding the company's financial health becomes

Simply Wall St -

Should You Be Holding Cross Country Healthcare, Inc. (NASDAQ:CCRN)?

(NASDAQ:CCRN) is a stock with outstanding fundamental characteristics. … When we build an investment case, we need to look at the stock with a holistic perspective. … In the case of CCRN, it

Simply Wall St -

Cross Country Healthcare, Inc. (NASDAQ:CCRN) Insiders Increased Their Holdings

So shareholders might well want to know whether insiders have been buying or selling shares in Cross Country Healthcare, Inc. … The Last 12 Months Of Insider Transactions At Cross Country Healthcare. … Overall, Cross Country Healthcare insiders were net buyers last year

Simply Wall St -

Should You Worry About Cross Country Healthcare Inc's (NASDAQ:CCRN) CEO Pay?

Bill Grubbs became the CEO of Cross Country Healthcare Inc (NASDAQ:CCRN) in 2013. … This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of similar size. … According to our data, Cross Country Healthcare Inc has a market capitalization of US$307m, and pays its CEO total annual compensation worth US$2.7m

Simply Wall St -

A Look At The Fair Value Of Cross Country Healthcare Inc (NASDAQ:CCRN)

In this article I am going to calculate the intrinsic value of Cross Country Healthcare Inc (NASDAQ:CCRN). … by projecting its future cash flows and then discounting them to today's value. … Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model

Simply Wall St -

What Does Cross Country Healthcare Inc's (NASDAQ:CCRN) PE Ratio Tell You?

and want to start learning about core concepts of fundamental analysis on practical examples from today's market. … Cross Country Healthcare Inc (NASDAQ:CCRN) is currently trading at a trailing P/E of 7.8, which is lower than the industry average of 22. … Check out our latest analysis for Cross Country Healthcare

Simply Wall St -

Why You Need To Look At This Factor Before Buying Cross Country Healthcare Inc (NASDAQ:CCRN)

If you're interested in Cross Country Healthcare Inc (NASDAQ:CCRN), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could impact your portfolio. … Beta is a widely used metric to measure a stock's exposure to market risk (volatility). … A stock with a beta below one is either less volatile than the market, or more volatile but not corellated with the overall market.

Simply Wall St -

At US$8.48, Is Cross Country Healthcare Inc (NASDAQ:CCRN) A Buy?

Cross Country Healthcare Inc (NASDAQ:CCRN), a healthcare company based in United States,. … A question to answer is whether Cross Country Healthcare's current trading price of $8.48 reflective of the actual value of the? … Let’s take a look at Cross Country Healthcare’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change

Simply Wall St -

Company Info

Description

Cross Country Healthcare, Inc. provides healthcare staffing, recruiting, and workforce solutions in the United States. The company operates in three segments: Nurse and Allied Staffing, Physician Staffing, and Other Human Capital Management Services. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, branch-based local nurses, and allied staffing; short-term staffing of registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and travel allied professionals on long-term contract assignments. It serves public and private acute care and non-acute care hospitals, government facilities, public and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, retailers, and other healthcare providers under the Cross Country Staffing, Mediscan, and DirectEd brands. The Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants under the Medical Doctor Associates brand as independent contractors on temporary assignments at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. The Other Human Capital Management Services segment offers retained and contingent search services for physicians, healthcare executives, nurses, advanced practice, and allied health professionals. Cross Country Healthcare, Inc. was founded in 1996 and is headquartered in Boca Raton, Florida.

Details
Name: Cross Country Healthcare, Inc.
CCRN
Exchange: NasdaqGS
Founded: 1996
$253,726,808
36,143,420
Website: http://www.crosscountryhealthcare.com
Address: Cross Country Healthcare, Inc.
5201 Congress Avenue,
Suite 100B,
Boca Raton,
Florida, 33487,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NasdaqGS CCRN Common Stock Nasdaq Global Select US USD 25. Oct 2001
DB XXY Common Stock Deutsche Boerse AG DE EUR 25. Oct 2001
Number of employees
Current staff
Staff numbers
1,750
Cross Country Healthcare employees.
Industry
Health Care Services
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/19 23:34
End of day share price update: 2019/04/18 00:00
Last estimates confirmation: 2019/04/17
Last earnings filing: 2019/03/01
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.